Latest diabetic gastroparesis Stories
-- Actavis has option to purchase Rhythm subsidiary, Rhythm Pharmaceuticals, Inc., upon successful completion of this study -- BOSTON and DUBLIN, April 8, 2015 /PRNewswire/ --Rhythm, a biopharmaceutical
- Clinical expert in diabetes and endocrinology - BOSTON, Dec. 11, 2014 /PRNewswire/ -- Rhythm announced today the appointment of Fred T. Fiedorek, MD, as Chief Medical Officer.
-- Relamorelin is a Novel Peptide Ghrelin Agonist for Diabetic Gastroparesis -- DUBLIN and BOSTON, Oct.
SAN DIEGO, May 5 /PRNewswire/ -- - Evoke Pharma, Inc., a privately-held specialty pharmaceutical company, announced today that it has initiated a Phase 2b clinical trial to evaluate EVK-001 for the treatment of adults with symptoms of diabetic gastroparesis.
- a slit in a tire to drain away surface water and improve traction.